Abstract:During the last two decades, tetrabutylammonium bromide (TBAB) has gained significant attention as an efficient metal-free homogeneous phase-transfer catalyst. A catalytic amount of TBAB is sufficient to catalyze various alkylation, oxidation, reduction, and esterification processes. It is also employed as an efficient co-catalyst for numerous coupling reactions. It has also acted as an efficient zwitterionic solvent in many organic transformations under molten conditions. In this review, we have summarized the recent developments on TBAB-catalyzed protocols for the efficient synthesis of various biologically promising heterocyclic scaffolds.
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the application of tetrabutylammonium bromide (TBAB) as an efficient metal - free homogeneous phase - transfer catalyst in the synthesis of various bioactive heterocyclic compounds. Specifically, the paper summarizes the latest progress in recent years in the effective synthesis of a variety of bioactive heterocyclic skeletons using TBAB - catalyzed protocols. These heterocyclic compounds have attracted attention due to their wide range of biological activities, such as anti - inflammatory, anti - malaria, anti - tuberculosis, anti - cancer, anti - asthma, anti - histamine, antihypertensive, antidepressant, antibacterial, anti - rheumatic, anti - diabetic, and the effects against various diseases such as Alzheimer's disease, Parkinson's disease and Huntington's disease.
By reviewing the catalytic performance of TBAB in different organic reactions, especially its unique ability to promote reactions between reactants in different phases, the paper shows the advantages of TBAB as an environmentally friendly, mild and biocompatible catalyst. The paper also discusses specific application cases of TBAB in the synthesis of bioactive N - heterocyclic compounds such as 1,4 - dihydropyridine, 2 - substituted imidazoline, 2,4,5 - triarylimidazole, 1,3 - dihydrobenzimidazol - 2 - one, pyrrolo[2,3 - d]pyrimidine derivatives, 2,3 - dihydroquinazolin - 4(1H) - one and 1,5 - benzodiazepine derivatives. Through these cases, the paper emphasizes the effectiveness of TBAB in increasing the reaction rate, product yield and simplifying the reaction conditions, especially in avoiding the use of metal - containing catalysts and toxic solvents.